ARCHIVES

Report Outlines “Grand Challenges” For Chemistry

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | March 7, 2003

Download PDF Visit The Full Archive

Related Articles

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

Centers Urged To Apply For Comprehensive Status By June 1

February 16, 1990

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

NCI Separates Carcinogenesis Research Efforts

February 18, 1977